Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

With mid-stage trial failure, Rigel pares focus to two drugs

It's one drug down, two more to go for Rigel Pharmaceuticals Inc. The South San Francisco-based drug developer (NASDAQ: RIGL) said Thursday that its experimental treatment for lupus patients with skin lesions failed a Phase II study — the company's third piece of bad news over the past 10 months...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.